Glass House Brands (GLAS) Preferred Shares (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Preferred Shares of $77.5 million for Q1 2026, up 14.82% year-over-year from $67.5 million in Q1 2025, and little changed quarter-over-quarter from $77.5 million in Q3 2025.
Glass House Brands (GLAS) Preferred Shares (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Preferred Shares for 6 consecutive years, with $77.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Shares rose 14.82% year-over-year to $77.5 million; the TTM figure through Mar 2026 stood at $77.5 million (up 14.82% YoY), while the FY2020 annual figure was $48.7 million, changed N/A from the prior year.
- Preferred Shares steadied at $77.5 million in Q1 2026 per GLAS's latest filing, from $77.5 million in the prior quarter.
- Across five years, Preferred Shares topped out at $77.5 million in Q3 2025 and bottomed at $51.8 million in Q1 2023.
- Historically, Preferred Shares has averaged $63.8 million across 4 years, with a median of $61.8 million in 2024.
- Annual changes were most pronounced in 2024 — Preferred Shares rose 11.67% — and 2025, when it increased 23.65%.
- Glass House Brands' Preferred Shares stood at $56.1 million in 2023, then climbed by 11.78% to $62.7 million in 2024, then increased by 23.65% to $77.5 million in 2025, then changed by 0.0% to $77.5 million in 2026.
- Business Quant data shows GLAS's Preferred Shares at $77.5 million in Q1 2026, $77.5 million in Q3 2025, and $70.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Glass House Brands | 829.33 Mn | 810.78 Mn | 15.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.50 Mn |
| Sep 30, 2025 | 77.50 Mn |
| Jun 30, 2025 | 70.04 Mn |
| Mar 31, 2025 | 67.50 Mn |
| Sep 30, 2024 | 62.68 Mn |
| Jun 30, 2024 | 60.88 Mn |
| Mar 31, 2024 | 59.17 Mn |
| Sep 30, 2023 | 56.07 Mn |
| Jun 30, 2023 | 54.52 Mn |
| Mar 31, 2023 | 51.77 Mn |
| Mar 31, 2021 | 48.69 Mn |
| Dec 31, 2020 | 48.69 Mn |